Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus.

Ünlü O, Zuily S, Erkan D.

Eur J Rheumatol. 2016 Jun;3(2):75-84. Review.

2.

The impact of positive acquired thrombophilia serology on ultrasound, obstetric outcome and the placenta in a low-risk primigravid population.

Cooley SM, Donnelly JC, Walsh T, Collins C, McMahon C, Gillan J, Geary MP.

Obstet Med. 2011 Mar;4(1):15-9. doi: 10.1258/om.2010.100057.

3.

Haematological manifestations of lupus.

Fayyaz A, Igoe A, Kurien BT, Danda D, James JA, Stafford HA, Scofield RH.

Lupus Sci Med. 2015 Mar 3;2(1):e000078. doi: 10.1136/lupus-2014-000078. Review.

4.

Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies.

Marder W, Romero VC, Ganser MA, Hyzy MA, Gordon C, McCune WJ, Somers EC.

Lupus Sci Med. 2014 Jul 15;1(1):e000034. doi: 10.1136/lupus-2014-000034.

5.

Transmission of lupus anticoagulant by allogeneic stem cell transplantation.

Massoud MR, William BM, Harrill K, Cooper BW, de Lima M, Schmaier AH.

Rev Bras Hematol Hemoter. 2014 Jul-Aug;36(4):287-9. doi: 10.1016/j.bjhh.2014.05.008.

6.

Retinal vasculitis in systemic lupus erythematosus: an indication of active disease.

Md Noh UK, Zahidin AZ, Yong TK.

Clin Pract. 2012 May 15;2(2):e54. doi: 10.4081/cp.2012.e54.

7.

Risk of Venous Thromboembolism in Patients Infected with HIV: A Cohort Study.

Sule AA, Pandit N, Handa P, Chadachan V, Tan E, Sum FN, Joyce EH, Chin TJ.

Int J Angiol. 2013 Jun;22(2):95-100. doi: 10.1055/s-0033-1333866.

8.

Aseptic necrosis at multiple localisations in a lupus patient with lymphoma.

Bazso A, Bazso T, Szodoray P, Poor G, Kiss E.

Osteoporos Int. 2014 Apr;25(4):1415-7. doi: 10.1007/s00198-013-2589-x.

9.

Prevalence of the antiphospholipid syndrome and its effect on survival in 679 Chinese patients with systemic lupus erythematosus: a cohort study.

Mok CC, Chan PT, Ho LY, Yu KL, To CH.

Medicine (Baltimore). 2013 Jul;92(4):217-22. doi: 10.1097/MD.0b013e31829cae47.

10.

Antiphospholipid-related chorea.

Peluso S, Antenora A, De Rosa A, Roca A, Maddaluno G, Brescia Morra V, De Michele G.

Front Neurol. 2012 Oct 22;3:150. doi: 10.3389/fneur.2012.00150.

11.

Thrombosis in systemic lupus erythematosus: a review article.

Al-Homood IA.

ISRN Rheumatol. 2012;2012:428269. doi: 10.5402/2012/428269.

12.

Rheumatic disease among Oklahoma tribal populations: a cross-sectional study.

Gaddy JR, Vista ES, Robertson JM, Dedeke AB, Roberts VC, Klein WS, Levin JH, Mota FH, Cooper TM, Grim GA, Khan S, James JA.

J Rheumatol. 2012 Oct;39(10):1934-41. doi: 10.3899/jrheum.110984.

13.

Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.

Relle M, Schwarting A.

Clin Dev Immunol. 2012;2012:584374. doi: 10.1155/2012/584374. Review.

14.

Genetic risk factors for thrombosis in systemic lupus erythematosus.

Kaiser R, Li Y, Chang M, Catanese J, Begovich AB, Brown EE, Edberg JC, McGwin G Jr, Alarcón GS, Ramsey-Goldman R, Reveille JD, Vilá LM, Petri MA, Kimberly RP, Taylor KE, Criswell LA.

J Rheumatol. 2012 Aug;39(8):1603-10. doi: 10.3899/jrheum.111451.

15.

Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.

Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Clarke A, Bernatsky S, Vasudevan A, Isenberg D, Rahman A, Wallace DJ, Fortin PR, Gladman D, Romero-Diaz J, Sanchez-Guerrero J, Dooley MA, Bruce I, Steinsson K, Khamashta M, Manzi S, Ramsey-Goldman R, Sturfelt G, Nived O, van Vollenhoven R, Ramos-Casals M, Aranow C, Mackay M, Kalunian K, Alarcón GS, Fessler BJ, Ruiz-Irastorza G, Petri M, Lim S, Kamen D, Peschken C, Farewell V, Thompson K, Theriault C, Merrill JT.

Ann Rheum Dis. 2011 Oct;70(10):1726-32. doi: 10.1136/ard.2010.148502. Erratum in: Ann Rheum Dis. 2011 Dec;70(12):2240. Romero-Dirz, J [corrected to Romero-Diaz, J].

16.

Dyslipidaemia in rheumatological autoimmune diseases.

Toms TE, Panoulas VF, Kitas GD.

Open Cardiovasc Med J. 2011;5:64-75. doi: 10.2174/1874192401105010064.

17.

Antiphospholipid syndrome; its implication in cardiovascular diseases: a review.

Koniari I, Siminelakis SN, Baikoussis NG, Papadopoulos G, Goudevenos J, Apostolakis E.

J Cardiothorac Surg. 2010 Nov 3;5:101. doi: 10.1186/1749-8090-5-101. Review.

18.

Prevalence of anticardiolipin antibodies in pregnancies with history of repeated miscarriages.

Spegiorin LC, Galão EA, Bagarelli LB, Oliani AH, de Godoy JM.

Open Rheumatol J. 2010 Aug 26;4:28-30. doi: 10.2174/1874312901004010028.

19.

Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.

Aranow C, Diamond B, Mackay M.

Rheum Dis Clin North Am. 2010 Feb;36(1):187-201, x-xi. doi: 10.1016/j.rdc.2009.12.007.

20.

An antibody profile of systemic lupus erythematosus detected by antigen microarray.

Fattal I, Shental N, Mevorach D, Anaya JM, Livneh A, Langevitz P, Zandman-Goddard G, Pauzner R, Lerner M, Blank M, Hincapie ME, Gafter U, Naparstek Y, Shoenfeld Y, Domany E, Cohen IR.

Immunology. 2010 Jul;130(3):337-43. doi: 10.1111/j.1365-2567.2010.03245.x.

Items per page

Supplemental Content

Support Center